Education
About Us
Working with TipRanks
Follow Us
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 169.12M | $ 27.96M | $ 0.00 | $ 0.00 | $ 22.33M |
| Gross Profit | $ 153.84M | $ 27.12M | $ -1.49M | $ -815.00K | $ 16.59M |
| Operating Income | $ -42.40M | $ -137.85M | $ -98.56M | $ -85.55M | $ -36.66M |
| EBITDA | $ -42.40M | $ -149.13M | $ -97.60M | $ -84.78M | $ -34.97M |
| Net Income | $ -48.83M | $ -160.28M | $ -137.46M | $ -77.33M | $ 7.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 73.78M | $ 105.11M | $ 96.50M | $ 157.22M | $ 221.40M |
| Total Assets | $ 164.24M | $ 164.70M | $ 132.78M | $ 247.26M | $ 311.64M |
| Total Debt | $ 1.70M | $ 35.38M | $ 131.02M | $ 145.00M | $ 130.52M |
| Net Debt | $ -49.67M | $ 4.22M | $ 57.04M | $ 94.30M | $ 58.80M |
| Total Liabilities | $ 90.39M | $ 76.96M | $ 153.93M | $ 169.02M | $ 149.37M |
| Stockholders' Equity | $ 73.85M | $ 87.74M | $ -21.14M | $ 78.24M | $ 162.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -46.91M | $ -128.51M | $ -71.02M | $ -77.34M | $ -48.83M |
| Operating Cash Flow | $ -46.91M | $ -128.51M | $ -70.30M | $ -77.31M | $ -48.73M |
| Investing Cash Flow | $ 51.78M | $ -50.09M | $ 79.70M | $ 56.93M | $ -69.72M |
| Financing Cash Flow | $ 15.97M | $ 135.34M | $ 14.54M | $ 263.00K | $ 179.68M |